Skip to content
NFA-VPS Over the Counter Companion Animal

Frontpro 11 mg Chewable Tablets for Dogs 2–4 kg

Active ingredient: Afoxolaner

Form

Chewable

Species

Dogs

Manufacturer

Boehringer Ingelheim Vetmedica GmbH

VMD MA No.

EU/2/19/240/001-004

What it's used for

Treatment of flea infestation in dogs (Ctenocephalides felis and C. canis). One treatment provides immediate and persistent flea killing activity for 5 wee...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Afoxolaner

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Clinical information

Frontpro 11 mg Chewable Tablets for Dogs 2–4 kg — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Treatment of flea infestation in dogs (Ctenocephalides felis and C. canis). One
treatment provides immediate and persistent flea killing activity for 5 weeks. The
product can be used as part of a treatment strategy for the control of flea allergy
dermatitis (FAD) where this has been previously diagnosed by a veterinarian.
Treatment of tick infestation in dogs (Dermacentor reticulatus, Ixodes ricinus,
Rhipicephalus sanguineus). One treatment provides immediate and persistent tick
killing activity for one month.
Fleas and ticks must attach to the host and commence feeding in order to be
exposed to the active substance.
For oral use.
Dosage:
The product should be administered at a dose of 2.7–7 mg/kg bodyweight in
accordance with the following table:
Strength and number of chewable tablets to be administeredBodyweight
of dog (kg)
FRONTPRO
11 mg
FRONTPRO
28 mg
FRONTPRO
68 mg
FRONTPRO
136 mg
2–41>4–101>10–251>25–501
For dogs above 50 kg bodyweight, use an appropriate combination of chewable
tablets of different/same strengths. The tablets should not be divided.
Underdosing could result in ineffective use and may favour resistance development.
To ensure a correct dosage, body weight should be determined as accurately as
possible before use.
Method of administration:
The tablets are chewable and palatable to most dogs. If the dog does not accept the
tablets directly they may be administered with food.

Revised: November 2024
AN: 03195/2023
Treatment schedule:
Treatment of flea and tick infestations:
For optimal control of flea and tick infestations, the product should be administered at
monthly intervals throughout the flea and/or tick seasons, based on local
epidemiological situations and the animal's lifestyle.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.

Revised: November 2024
AN: 03195/2023
Mild gastrointestinal effects (vomiting, diarrhoea), pruritus, lethargy, anorexia, and
neurological signs (convulsions, ataxia and muscle tremors) have been reported very
rarely. Most reported adverse reactions were self-limiting and of short duration.

Revised: November 2024
AN: 03195/2023
The frequency of adverse reactions is defined using the following convention:
•
reaction(s))
•
•
•
•
reports).
Unnecessary use of antiparasitics or use deviating from the instructions provided
may increase the resistance selection pressure and lead to reduced efficacy. The
decision to use the product should be based on confirmation of the parasitic species
and burden, or of the risk of infestation based on its epidemiological features, for
each individual animal.
Parasites need to start feeding on the host to become exposed to afoxolaner;
therefore the risk of the transmission of parasite borne diseases cannot be excluded.
When treating infestations of parasites, all in-contact animals should be treated with
an appropriate product at the same time.
All stages of fleas can infest the dog’s bedding and regular resting areas such as
carpets and soft furnishings. In case of massive flea infestation and at the beginning
of the control measures, these areas should be treated with a suitable environmental
product and then vacuumed regularly.
Activity of the product is not affected if treated dogs are exposed to water.

Special precautions for use in animals
In the absence of available data, a veterinary surgeon should be consulted before
treatment of puppies less than 8 weeks of age and/or dogs less than 2 kg
bodyweight.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
This product may be harmful following ingestion.
To prevent children from getting access to the veterinary medicinal product, remove
only one chewable tablet at a time from the blister. Return the blister with the
remaining chewable tablets into the carton.
Wash hands after handling the product.
Other precautions
The active substance is mostly excreted in the faeces (poo) and may be toxic to non-
target organisms. To avoid contamination of the environment, ensure that dog
faeces are bagged up and disposed of safely.
None known.
This veterinary medicinal product does not require any special storage conditions.
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Related Conditions

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.